82 related articles for article (PubMed ID: 709936)
21. [Osteoporotic changes in rheumatoid arthritis--longitudinal bone mass study and effect of 1 alpha-hydroxyvitamin D3].
Teshima R
Nihon Seikeigeka Gakkai Zasshi; 1988 Mar; 62(3):171-8. PubMed ID: 3392446
[TBL] [Abstract][Full Text] [Related]
22. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
[TBL] [Abstract][Full Text] [Related]
23. 1-Alpha-OH-cholecalciferol (1-alpha-OH-D3) and optimal calcium intake in calcium deficiency osteoporosis mediated by parathyroid activity morphologic and biochemical changes in adult male rats.
Lindholm TS; Nilsson OS; Lindholm TC
Acta Vitaminol Enzymol; 1985; 7(1-2):39-47. PubMed ID: 4036758
[TBL] [Abstract][Full Text] [Related]
24. Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.
Matloff DS; Kaplan MM; Neer RM; Goldberg MJ; Bitman W; Wolfe HJ
Gastroenterology; 1982 Jul; 83(1 Pt 1):97-102. PubMed ID: 7075948
[TBL] [Abstract][Full Text] [Related]
25. Treatment of senile osteoporosis with 1alpha-hydroxyvitamin D3.
Sørensen OH; Andersen RB; Christensen MS; Friis T; Hjorth L; Jørgensen FS; Lund B; Melsen F; Mosekilde L
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():169s-175s. PubMed ID: 342143
[TBL] [Abstract][Full Text] [Related]
26. Treatment of patients with senile, post-menopausal and corticosteroid-induced osteoporosis with 1alpha-hydroxyvitamin D3 and calcium: short- and long-term effects.
Lindholm TS; Sevastikoglou JA; Lindgren U
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():183s-189s. PubMed ID: 606416
[No Abstract] [Full Text] [Related]
27. The effect of 1alpha-hydroxyvitamin D3 with and without oestrogens on calcium balance in post-menopausal women.
Marshall DH; Nordin BE
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():159s-168s. PubMed ID: 606414
[TBL] [Abstract][Full Text] [Related]
28. Zinc and osteoporosis in patients with spinal cord injury.
Ohry A; Shemesh Y; Zak R; Herzberg M
Paraplegia; 1980 Jun; 18(3):174-80. PubMed ID: 7413239
[TBL] [Abstract][Full Text] [Related]
29. Effect of 1 alpha-hydroxyvitamin D3 on osteoporosis induced by immobilization combined with ovariectomy in rats.
Okumura H; Yamamuro T; Kasai R; Hayashi T; Tada K; Nishii Y
Bone; 1987; 8(6):351-5. PubMed ID: 3449110
[TBL] [Abstract][Full Text] [Related]
30. Fluoride therapy and parathyroid hormone activity in osteoporosis.
Stamp TC; Saphier PW; Loveridge N; Kelsey CR; Goldstein AJ; Katakity M; Jenkins MV; Rose GA
Clin Sci (Lond); 1990 Sep; 79(3):233-8. PubMed ID: 2169371
[TBL] [Abstract][Full Text] [Related]
31. [Urinary excretion of calcium after administration of 1 alpha-hydroxyvitamin D3 in idiopathic juvenile osteoporosis].
Wieczorek E; Pronicka W; Ruszczak A
Pol Tyg Lek; 1988 Nov; 43(48):1537-9. PubMed ID: 3255905
[No Abstract] [Full Text] [Related]
32. 1 alpha-Hydroxycholecalciferol and calcium deficiency osteoporosis in adult rats.
Lindholm TS
Scand J Rheumatol; 1979; 8(4):257-63. PubMed ID: 534319
[TBL] [Abstract][Full Text] [Related]
33. 1 alpha-hydroxyvitamin D3 in intestinal calcium malabsorption. A pilot study.
Hylander E; Jarnum S
Scand J Gastroenterol; 1980; 15(4):443-8. PubMed ID: 7433906
[TBL] [Abstract][Full Text] [Related]
34. The ultra long-term treatment of senile osteoporosis with 1 alpha-hydroxyvitamin D3.
Shiraki M; Ito H; Orimo H
Bone Miner; 1993 Mar; 20(3):223-34. PubMed ID: 8490326
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of severe postmenopausal osteoporosis].
Reĭsner NA; Babarykin DA; Vorona IG; Riabukha AN; Rozental' RL
Probl Endokrinol (Mosk); 1988; 34(4):13-6. PubMed ID: 3194355
[TBL] [Abstract][Full Text] [Related]
36. Calcium and phosphorus metabolism and lithogenic factors in patients with osteoporotic fracture.
Ochoa-Hortal Rull MÁ; Cano-García MC; Arrabal Martín M; Cano Gea R; Reyes García R; Arrabal-Polo MA
Actas Urol Esp; 2015 Jun; 39(5):279-82. PubMed ID: 25709002
[TBL] [Abstract][Full Text] [Related]
37. [Immunocorrecting properties and effect on the phosphorus-calcium metabolism of oxidevit (1 alpha-hydroxyvitamin D3)].
Babarykin DA; Vasipa SB; Gintere GB; Bigestan VIa
Vopr Med Khim; 1988; 34(4):104-9. PubMed ID: 3195123
[TBL] [Abstract][Full Text] [Related]
38. Combined treatment of post-menopausal osteoporosis: effect on muscle function and a new radiological method for assessing trabecular bone.
Crisp AJ; Buckland-Wright JC; Kauffmann EA; Gibson T
Curr Med Res Opin; 1984; 8(10):701-7. PubMed ID: 6723347
[TBL] [Abstract][Full Text] [Related]
39. Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium.
Hoikka V; Alhava EM; Aro A; Karjalainen P; Rehnberg V
Acta Med Scand; 1980; 207(3):221-4. PubMed ID: 6989171
[TBL] [Abstract][Full Text] [Related]
40. Effect of 1 alpha-hydroxyvitamin D3 and dietary calcium and phosphate on the aortic mineral content in rabbits with mild azotemia.
Tvedegaard E; Ladefoged O; Nielsen M; Kamstrup O
Nephron; 1983; 34(3):185-91. PubMed ID: 6877450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
